[ad_1]
It will take three weeks to process applications from German pharmaceutical company BioNTech and its American partner Pfizer for the registration of the covid vaccine in the United States, the New York Times reported.
All on the topic:
Coronavirus epidemic (COVID-19) 15454
According to the publication, for so long the specialists of the Food and Drug Administration (FDA) will consider the application of the two companies. It will then be considered by a panel of independent experts scheduled for December 10.
Therefore, the vaccine can be approved for use in mid-December.
Previously, the two companies announced that they were ready to begin distributing the vaccine within hours of approval.
Novini.bg allows you to follow the latest data on the deadly coronavirus in real time:
All on the topic:
Coronavirus epidemic (COVID-19)
15454
More about the coronavirus
[ad_2]
